Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02621424 · ClinicalTrials.gov registry record · NA
Repetitive Transcranial Magnetic Stimulation for Dementia
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT02621424: Completed NA study, sponsored by VA Office of Research and Development.
NCT02621424 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 32 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02621424, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
The purpose is to is to study if repetitive transcranial magnetic stimulation (rTMS) improves cognitive function in patients with neurodegenerative conditions which may manifest as mild to moderate cognitive impairment and, in late phase, dementia. This study also intends to investigate if the responses to rTMS intervention are either positively or negatively correlated with the initial severity of cognitive impairment.
Interventions
- DEVICE sham
- DEVICE RTMS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2016-01-01 |
| Est. Completion | 2025-09-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02621424
The ClinicalTrials.gov registry entry for NCT02621424 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which sham is the first listed.
NCT02621424 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02621424 about?
NCT02621424 is a clinical study titled "Repetitive Transcranial Magnetic Stimulation for Dementia". The purpose is to is to study if repetitive transcranial magnetic stimulation (rTMS) improves cognitive function in patients with neurodegenerative conditions which may manifest as mild to moderate cognitive impairment and, in late phase, dementia. This study also intends to investigate if the respo...
What is the current status of trial NCT02621424?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2016-01-01. Estimated completion is 2025-09-16.
What interventions are being tested in trial NCT02621424?
The interventions under investigation include: sham (DEVICE), RTMS (DEVICE).
Who is sponsoring clinical trial NCT02621424?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.